跳至主要内容
临床试验/NCT04696978
NCT04696978Unknown不适用

Metabonomics Characteristics and Predictive Value for Perioperative Neurocognitive Disorders After Deep Brain Stimulation Surgery for Parkinson's Disease

wenbinlu1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2020年8月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
300
试验地点
1
主要终点
the level of metabolomics in patients' blood sample

研究概览

简要总结

Perioperative neurocognitive disorders(PND) is common to see in elderly patients. Although PND increases patient mortality as well as hospitalization time, apparent inflammatory factors, and related mechanisms are still unknown. Metabolites could reveal chemical fingerprints left behind by cellular processes, which in turn provide a new aspect to understand the biological process behind. we aim to found the metabolomics can aid the development of diagnostic markers of PND screening, early detection, and further, provide a basis for disease prevention and treatment.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Parkinson's patients undergoing elective deep brain stimulation
  • Age ≥55 years
  • ASA physical statusⅠ-Ⅲ
  • Elementary school or above

排除标准

  • patients with ASA physical status>III
  • patients with systemic immune diseases, hematological diseases (hematological tumors or leukemia), patients after transplantation, malignant tumors
  • patients with metabolic diseases such as diabetes, ketoacidosis, hyperosmolar syndrome, long-term hypoglycemia,gout
  • patients who refused to join the study and lost to follow-up

结局指标

主要结局

the level of metabolomics in patients' blood sample

时间窗: 72 hours after operation

次要结局

  • CAM-ICU score(1 month after operation)

研究者

发起方
wenbinlu
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

wenbinlu

Principal Investigator

Changhai Hospital

研究点 (1)

Loading locations...

相似试验